First Drug Targets Rare Lung Cancer Mutation | Los Angeles News

Presented by The Plant Daddies — rare specimen trees, living art, and hand-carved limestone vessels and fountains for extraordinary spaces. Showrooms in Los Angeles and Irvine. Listeners of Los Angeles News Today receive 10% off with code LANEWS10. theplantdaddies.com/lanews FDA just approved the first-ever drug specifically targeting a rare, long-ignored lung cancer mutation—KRAS G12C—offering new hope to patients who’ve had few options. After decades of research, this breakthrough drug blocks the mutated protein that fuels tumor growth, showing real tumor shrinkage in trials. It’s a major win for precision medicine, proving that understanding a cancer’s genetic roots can lead to smarter, more effective treatments—and it’s just the beginning. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6da3c5306421acd8